对近10年来有关中医辨治胃癌前病变(precancerous lesions of gastric cancer,PLGC)的研究进行综述。PLGC是指在慢性萎缩性胃炎基础上出现的胃黏膜肠上皮化生和异型增生,作为慢性萎缩性胃炎与胃癌的中间阶段,PLGC的病程较缓慢。中医辨治...对近10年来有关中医辨治胃癌前病变(precancerous lesions of gastric cancer,PLGC)的研究进行综述。PLGC是指在慢性萎缩性胃炎基础上出现的胃黏膜肠上皮化生和异型增生,作为慢性萎缩性胃炎与胃癌的中间阶段,PLGC的病程较缓慢。中医辨治PLGC具有一定的优势。PLGC主要可分为脾胃虚弱证、脾胃湿热证、肝胃气滞证、胃络瘀阻证、胃阴不足证5种证型。胃镜技术的普及促进了胃病微观辨证的发展,微观辨证与宏观辨证的结合为PLGC的中医辨证论治提供了更加丰富的理论支持。PLGC根本病机为脾胃虚弱,脾胃气机不畅,兼有湿热、瘀毒、痰湿等病理因素蕴结,日久胃阴亏耗。中药治疗PLGC的临床研究开展较多,治疗主要采用以益气健脾为主,兼以疏肝活血、化湿消瘀、化瘀解毒、养阴益胃,从而防止PLGC向胃癌进一步发展。针灸治疗胃癌前病变的研究开展较少。今后需开展更多严格且规范的多中心、大样本的临床随机对照试验,深入研究针灸治疗胃癌前病变机制,以期为中医辨治PLGC提供更多高级别的循证依据。展开更多
Objective: To investigate the effect of Chinese drugs (CD) that invigorate Spleen to remove Dampness and activate the blood circulation to eliminate Turbid for retarding progression of chronic renal failure (CRF).Meth...Objective: To investigate the effect of Chinese drugs (CD) that invigorate Spleen to remove Dampness and activate the blood circulation to eliminate Turbid for retarding progression of chronic renal failure (CRF).Methods: Thirty-nine patients with CRF were divided into two groups at random: the 18 patients in group A (the control group) were treated with low protein diet and controlling blood pressure and 21 patients in group B (the treatment group) were treated similarly with that of the control group and additional CD. Levels of serous creatinine (SCr), blood urea nitrogen (BUN), blood albumin (Alb), total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL) and hemoglobin (Hb) were checked every two months and the rate of progression of CRF was estimated by slope of the creatinine reciprocal (1/SCr) with time (months).Results: Levels of SCr and BUn in group B were lower and HDL higher than those in group A significantly,P < 0.05. Mean slopes of the creatinine reciprocal with time in the two groups were markedly different,P < 0.01.Conclusion: Additional CD treatment based upon the low protein diet and controlling blood pressure could retard the rate of progression of CRF evidently.展开更多
目的探讨健脾消痰方结合常规减肥措施治疗脾虚痰湿型肥胖症临床效果。方法按照随机数表法将92例脾虚痰湿型肥胖症患者分成对照组和观察组,各46例。对照组采用调整饮食生活方式减肥方法,观察组在对照组常规减肥措施基础上联合健脾消痰方...目的探讨健脾消痰方结合常规减肥措施治疗脾虚痰湿型肥胖症临床效果。方法按照随机数表法将92例脾虚痰湿型肥胖症患者分成对照组和观察组,各46例。对照组采用调整饮食生活方式减肥方法,观察组在对照组常规减肥措施基础上联合健脾消痰方治疗。观察2组治疗前后临床症状积分(食少纳呆、脘腹痞闷、头身困重、大便溏泄)、身体质量指数(BMI)、腰围、臀围、空腹血糖(FBG)、餐后2 h血糖(2 hFBG)、血清总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、白细胞介素1β(IL^(-1)β)、白细胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)水平变化情况,并比较2组治疗总有效率及安全性。结果观察组治疗后BMI、腰围、臀围、FBG、2 h FBG、TG、TC、LDL-C水平,IL-6、IL^(-1)β、TNF-α水平均低于对照组(P<0.05),HDL-C水平、治疗总有效率均高于对照组(P<0.05);2组均无明显用药不良反应发生。结论健脾消痰方结合常规减肥措施治疗脾虚痰湿型肥胖症疗效确切,安全有效,能够有效调节糖脂代谢紊乱,抑制炎性因子表达,减轻肥胖程度。展开更多
文摘对近10年来有关中医辨治胃癌前病变(precancerous lesions of gastric cancer,PLGC)的研究进行综述。PLGC是指在慢性萎缩性胃炎基础上出现的胃黏膜肠上皮化生和异型增生,作为慢性萎缩性胃炎与胃癌的中间阶段,PLGC的病程较缓慢。中医辨治PLGC具有一定的优势。PLGC主要可分为脾胃虚弱证、脾胃湿热证、肝胃气滞证、胃络瘀阻证、胃阴不足证5种证型。胃镜技术的普及促进了胃病微观辨证的发展,微观辨证与宏观辨证的结合为PLGC的中医辨证论治提供了更加丰富的理论支持。PLGC根本病机为脾胃虚弱,脾胃气机不畅,兼有湿热、瘀毒、痰湿等病理因素蕴结,日久胃阴亏耗。中药治疗PLGC的临床研究开展较多,治疗主要采用以益气健脾为主,兼以疏肝活血、化湿消瘀、化瘀解毒、养阴益胃,从而防止PLGC向胃癌进一步发展。针灸治疗胃癌前病变的研究开展较少。今后需开展更多严格且规范的多中心、大样本的临床随机对照试验,深入研究针灸治疗胃癌前病变机制,以期为中医辨治PLGC提供更多高级别的循证依据。
文摘Objective: To investigate the effect of Chinese drugs (CD) that invigorate Spleen to remove Dampness and activate the blood circulation to eliminate Turbid for retarding progression of chronic renal failure (CRF).Methods: Thirty-nine patients with CRF were divided into two groups at random: the 18 patients in group A (the control group) were treated with low protein diet and controlling blood pressure and 21 patients in group B (the treatment group) were treated similarly with that of the control group and additional CD. Levels of serous creatinine (SCr), blood urea nitrogen (BUN), blood albumin (Alb), total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL) and hemoglobin (Hb) were checked every two months and the rate of progression of CRF was estimated by slope of the creatinine reciprocal (1/SCr) with time (months).Results: Levels of SCr and BUn in group B were lower and HDL higher than those in group A significantly,P < 0.05. Mean slopes of the creatinine reciprocal with time in the two groups were markedly different,P < 0.01.Conclusion: Additional CD treatment based upon the low protein diet and controlling blood pressure could retard the rate of progression of CRF evidently.
文摘目的探讨健脾消痰方结合常规减肥措施治疗脾虚痰湿型肥胖症临床效果。方法按照随机数表法将92例脾虚痰湿型肥胖症患者分成对照组和观察组,各46例。对照组采用调整饮食生活方式减肥方法,观察组在对照组常规减肥措施基础上联合健脾消痰方治疗。观察2组治疗前后临床症状积分(食少纳呆、脘腹痞闷、头身困重、大便溏泄)、身体质量指数(BMI)、腰围、臀围、空腹血糖(FBG)、餐后2 h血糖(2 hFBG)、血清总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、白细胞介素1β(IL^(-1)β)、白细胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)水平变化情况,并比较2组治疗总有效率及安全性。结果观察组治疗后BMI、腰围、臀围、FBG、2 h FBG、TG、TC、LDL-C水平,IL-6、IL^(-1)β、TNF-α水平均低于对照组(P<0.05),HDL-C水平、治疗总有效率均高于对照组(P<0.05);2组均无明显用药不良反应发生。结论健脾消痰方结合常规减肥措施治疗脾虚痰湿型肥胖症疗效确切,安全有效,能够有效调节糖脂代谢紊乱,抑制炎性因子表达,减轻肥胖程度。
